Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. provides medical devices and solutions in China and internationally. The company offers various products, including patient monitoring, ultrasound, radiology, AED, defibrillation system, anesthesia, CLIA, chemistry, hematology, ventilators, electrocardiograph, endoscope camera system, operating tables, surgical lights, medical supply units, acces… Read more
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A (300760) - Net Assets
Latest net assets as of September 2025: CN¥44.24 Billion CNY
Based on the latest financial reports, Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A (300760) has net assets worth CN¥44.24 Billion CNY as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥59.27 Billion) and total liabilities (CN¥15.02 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥44.24 Billion |
| % of Total Assets | 74.66% |
| Annual Growth Rate | 15.48% |
| 5-Year Change | 75.0% |
| 10-Year Change | 523.4% |
| Growth Volatility | 42.15 |
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A - Net Assets Trend (2014–2024)
This chart illustrates how Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A (2014–2024)
The table below shows the annual net assets of Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A from 2014 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥40.76 Billion | +22.23% |
| 2023-12-31 | CN¥33.35 Billion | +4.21% |
| 2022-12-31 | CN¥32.00 Billion | +18.66% |
| 2021-12-31 | CN¥26.97 Billion | +15.79% |
| 2020-12-31 | CN¥23.29 Billion | +25.10% |
| 2019-12-31 | CN¥18.62 Billion | +22.66% |
| 2018-12-31 | CN¥15.18 Billion | +128.10% |
| 2017-12-31 | CN¥6.65 Billion | +44.63% |
| 2016-12-31 | CN¥4.60 Billion | -29.63% |
| 2015-12-31 | CN¥6.54 Billion | -32.33% |
| 2014-12-31 | CN¥9.66 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 243.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥27.62 Billion | 77.03% |
| Common Stock | CN¥1.21 Billion | 3.38% |
| Other Components | CN¥7.02 Billion | 19.59% |
| Total Equity | CN¥35.86 Billion | 100.00% |
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A Competitors by Market Cap
The table below lists competitors of Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Federal Home Loan Mortgage Corp Pref Perpetual
OTCQB:FMCCT
|
$12.56 Billion |
|
BSE Limited
NSE:BSE
|
$12.57 Billion |
|
Symrise AG
PINK:SYIEF
|
$12.58 Billion |
|
XPENG INC. CL.A DL-00001
F:8XP
|
$12.58 Billion |
|
China Coal Energy Co Ltd
SHG:601898
|
$12.54 Billion |
|
Iflytek Co Ltd
SHE:002230
|
$12.52 Billion |
|
Informa plc
PINK:IFPJF
|
$12.50 Billion |
|
Alibaba Health Information Technology Limited
PINK:ALBBY
|
$12.50 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 33,085,389,686 to 35,856,358,850, a change of 2,770,969,164 (8.4%).
- Net income of 11,668,487,000 contributed positively to equity growth.
- Dividend payments of 8,742,501,634 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥11.67 Billion | +32.54% |
| Dividends Paid | CN¥8.74 Billion | -24.38% |
| Other Changes | CN¥-155.02 Million | -0.43% |
| Total Change | CN¥- | 8.38% |
Book Value vs Market Value Analysis
This analysis compares Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 5.99x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 17.58x to 5.99x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | CN¥10.08 | CN¥177.25 | x |
| 2015-12-31 | CN¥6.86 | CN¥177.25 | x |
| 2016-12-31 | CN¥4.55 | CN¥177.25 | x |
| 2017-12-31 | CN¥6.06 | CN¥177.25 | x |
| 2018-12-31 | CN¥13.61 | CN¥177.25 | x |
| 2019-12-31 | CN¥15.29 | CN¥177.25 | x |
| 2020-12-31 | CN¥19.15 | CN¥177.25 | x |
| 2021-12-31 | CN¥22.19 | CN¥177.25 | x |
| 2022-12-31 | CN¥26.42 | CN¥177.25 | x |
| 2023-12-31 | CN¥27.30 | CN¥177.25 | x |
| 2024-12-31 | CN¥29.60 | CN¥177.25 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 32.54%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 31.77%
- • Asset Turnover: 0.65x
- • Equity Multiplier: 1.58x
- Recent ROE (32.54%) is above the historical average (28.09%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 14.58% | 17.35% | 0.54x | 1.56x | CN¥427.30 Million |
| 2015 | 14.28% | 11.35% | 0.65x | 1.94x | CN¥272.54 Million |
| 2016 | 35.41% | 17.72% | 0.70x | 2.87x | CN¥1.15 Billion |
| 2017 | 39.11% | 23.17% | 0.77x | 2.18x | CN¥1.93 Billion |
| 2018 | 24.54% | 27.04% | 0.64x | 1.43x | CN¥2.20 Billion |
| 2019 | 25.17% | 28.27% | 0.65x | 1.38x | CN¥2.82 Billion |
| 2020 | 28.60% | 31.66% | 0.63x | 1.43x | CN¥4.33 Billion |
| 2021 | 29.69% | 31.66% | 0.66x | 1.41x | CN¥5.31 Billion |
| 2022 | 30.04% | 31.64% | 0.65x | 1.46x | CN¥6.41 Billion |
| 2023 | 35.01% | 33.16% | 0.73x | 1.45x | CN¥8.27 Billion |
| 2024 | 32.54% | 31.77% | 0.65x | 1.58x | CN¥8.08 Billion |
Industry Comparison
This section compares Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $2,121,810,098
- Average return on equity (ROE) among peers: 128.89%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A (300760) | CN¥44.24 Billion | 14.58% | 0.34x | $12.55 Billion |
| Shanghai Kehua Bio-Engineering Co Ltd (002022) | $1.03 Billion | 22.10% | 0.17x | $320.58 Million |
| Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) | $6.16 Billion | 12.22% | 0.29x | $2.80 Billion |
| Double Medical Technology Inc (002901) | $3.11 Billion | 2.98% | 0.27x | $405.66 Million |
| Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) | $21.45K | 1180.66% | 90.26x | $283.55 Million |
| Lepu Medical Tech Beijing (300003) | $7.03 Billion | 12.79% | 0.82x | $2.80 Billion |
| INKON Life Technology Co Ltd (300143) | $74.89 Million | 13.27% | 0.87x | $630.90 Million |
| Edan Instruments Inc (300206) | $152.19 Million | 30.16% | 0.31x | $509.86 Million |
| Guangdong Biolight Meditech Co Ltd (300246) | $1.29 Billion | -5.53% | 0.94x | $378.42 Million |
| Beijing Leadman Biochemistry Co Ltd (300289) | $1.44 Billion | 2.82% | 0.20x | $269.46 Million |
| Sinocare Inc (300298) | $946.01 Million | 17.47% | 0.11x | $952.60 Million |